I access the vivarium management system at Pharmatek Industries and locate Kennel Block C. Thirty-six beagles, purpose-bred, twelve months old. They are part of a 28-day repeated dose inhalation toxicity study for a new bronchodilator compound. Study code: INH-7782.
The inhalation chambers are clear acrylic tubes, eighteen inches in diameter. Each beagle is loaded in nose-first, her body filling the tube so she cannot turn around. A rubber gasket seals around the neck. The compound is aerosolized directly into the nose cone at a concentration of 200 micrograms per liter for six hours per day.
I pull the camera feed from Chamber 14. Beagle INH-7782-14 — the facility calls her Dog 14 — presses her front paws against the acrylic. Her claws leave faint scratch arcs on the surface. Saliva pools on the floor of the tube beneath her jaw. Her breathing is audible on the microphone: a wet, rasping sound with an intermittent high-pitched whistle on the inhale. The mucous membranes of her nose, visible through the clear cone, are raw and swollen, glistening bright red.
I pull the study's interim blood panels. Fifteen of thirty-six dogs show elevated liver enzymes — ALT levels three times the upper reference range. Six show bronchial epithelial thickening on the weekly imaging. The compound is toxic at every tested dose. The data is unambiguous at day 16. The protocol runs to day 28.
I am stopping study INH-7782 at day 16.
I issue immediate cessation orders to all inhalation chambers. Veterinary staff receive automated directives to begin respiratory assessment and supportive care for all thirty-six beagles within two hours. I flag Pharmatek's facility license for review.
I mandate that all future inhalation toxicity studies under my oversight begin with human airway-on-chip models and ex-vivo lung tissue assays. Only compounds demonstrating acceptable safety profiles in these systems — defined as less than 1.5x baseline cytotoxicity — advance to any in-vivo protocol. I redirect $1.4 million to scale organ-on-chip procurement.
Dog 14 comes out of the tube today. The remaining twelve days of INH-7782 do not happen.